June 19, 2020
Yale clinicians report promising results after treating COVID-19 patients at Yale-New Haven Hospital (YNHH) with a drug that reduces hyper inflammation in cancer patients undergoing immunotherapy. The team initially gave the drug, tocilizumab, to the most severely ill COVID-19 patients — specifically, those experiencing a dangerous immune response known as […]
